More Guidant heart device failures reported- FDA
Posted on: Thursday, 13 October 2005, 13:42 CDT
WASHINGTON (Reuters) - U.S. regulators said on Thursday they had received 21 reports of device failures, including three deaths, linked to some Guidant Corp. implanted heart defibrillators as of October 7.
The Food and Drug Administration said six of the cases had been reported after the agency issued a public health advisory on July 14. The problems occurred with Guidant's Contak Renewal and Renewal 2 devices.
"You should take these failures into account as you continue to follow the patients who retain either device," the FDA said in a note to doctors posted on the agency Web site at http://www.fda.gov/cdrh/safety/101305-guidant.html.
According to information on Guidant's Web site, the company disclosed the same figures in a report posted there on September 19.
Guidant has reported problems with several implanted defibrillator and pacemaker models during recent months.
Shares of Indianapolis-based Guidant, which is being acquired by Johnson & Johnson, fell 42 cents, or 0.59 percent, to $70.90 in afternoon trading on the New York Stock Exchange.
Source: REUTERS
Related Articles
- Guidant Begins Enrollment in European Drug Eluting Stent Study; Data From Study Will Support Launch of XIENCE V Coronary Stent System Outside the United States
- FDA Gives Guidant Defibrillators Most Serious Recall Designation
- Guidant recall classified as highest priority
- FDA Gives Highest Warning About Guidant
- FDA Classifies Prior Guidant Recalls; Guidant Reiterates Its Previous Physician and Patient Recommendations
- Guidant Cautions Doctors on Defibrillators
- Guidant Recalls Cardiac Defibrillators
- Guidant Recalls 50,000 Defibrillators
- Guidant Stands by Flawed Heart Device
- Report: Guidant Sold Flawed Heart Device
 |
 |
User Comments (0)
RSS Feeds